跳至主要内容
临床试验/NCT01230216
NCT01230216终止4 期

Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound

Takeshi Morimoto1 个研究点 分布在 1 个国家目标入组 8 人开始时间: 2010年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
入组人数
8
试验地点
1
主要终点
change of percent atheroma volume

研究概览

简要总结

The purpose of this study is to evaluate the effect of intensive blood pressure control compared to standard blood pressure control on progression of coronary atherosclerosis by intravascular ultrasound in hypertensive patients with coronary artery disease.

详细描述

Antihypertensive therapy is reported to reduce cardiovascular events in patients with coronary artery disease. The goal of blood pressure in patients with coronary artery disease is recommended to control below 140/90mmHg. However, the effect of intensive blood pressure control compared to standard blood pressure control is still unknown. The purpose of this study is to evaluate the effect of intensive blood pressure control compared to standard blood pressure control on progression of coronary atherosclerosis by intravascular ultrasound in hypertensive patients with coronary atherosclerosis after 18 months. The goal of systolic blood pressure is under 120mmHg in intensive blood pressure control group and under 140mmHg in standard blood pressure control group. The design of this study is randomized control study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • coronary artery diseases which require coronary angiography or percutaneous coronary intervention
  • primary hypertension (systolic blood pressure 140-180mmHg within one month)

排除标准

  • severe hypertension
  • secondary hypertension
  • treated with more than three antihypertensive drugs
  • left main trunk trunk coronary artery disease
  • moderate heart failure
  • severe valvular disease
  • liver dysfunction renal dysfunction (Cr>=2.0mg/dl) Pregnant or nursing women severe arrhythmia

研究组 & 干预措施

intensive blood pressure control

Active Comparator

systolic blood pressure less than 120 mmHg

干预措施: control systolic blood pressure less than 120 mmHg (Drug)

standard blood pressure control

Active Comparator

systolic blood pressure less than 140 mmHg

干预措施: control systolic blood pressure less than 140 mmHg (Drug)

结局指标

主要结局

change of percent atheroma volume

时间窗: 1.5-year

change of percent atheroma volume measured by intravascular ultrasound

次要结局

  • all cause death(1.5-year)
  • cardiac death(1.5-year)
  • cardiovascular death(1.5-year)
  • myocardial infarction(1.5-year)
  • stroke(1.5-year)
  • target-lesion revascularization(1.5-year)
  • any coronary revascularization(1.5-year)
  • hospitalization due to angina pectoris(1.5-year)
  • hospitalization due to heart failure(1.5-year)
  • change of total atheroma volume(1.5-year)
  • percent change of total atheroma volume(1.5-year)
  • change of atheroma volume at most severe 10mm lesion(1.5-year)

研究者

发起方
Takeshi Morimoto
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Takeshi Morimoto

Professor

Kyoto University, Graduate School of Medicine

研究点 (1)

Loading locations...

相似试验

Effect of Intensive Blood Pressure Control on... | 临床试验